La Jolla, CANCT06884059Now EnrollingIRB Ready

Type 2 Diabetes Mellitus (T2DM) Clinical Trial in La Jolla, CA

Access cutting-edge type 2 diabetes mellitus (t2dm) treatment through this phase 1 clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Diego

Quick Self-Assessment

See if you qualify for this La Jolla location

Preparing your pre-screening questions…

Expert Care in La Jolla

Access type 2 diabetes mellitus (t2dm) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 2 diabetes mellitus (t2dm) treatment provided free

Apply for This La Jolla Location

Check if you qualify for this type 2 diabetes mellitus (t2dm) clinical trial in La Jolla, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to La Jolla

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit La Jolla site if eligible
  4. 4Begin participation

About This Type 2 Diabetes Mellitus (T2DM) Study in La Jolla

This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.

Sponsor: University of California, San Diego

Who Can Participate

Inclusion Criteria

Age: 18-75 years old
Participants with T2DM with A1c between 6.5 and 9.0 % and on stable doses of medications who are weight-bearing and self-ambulatory.
uACR ( urine albumin creatinine ratio) results ≥ 30 - 300 mg.
Willingness to use smartphone for research procedures (Apple iOS or Android OS)
Baseline eating period ≥12 hours/day and sufficient logging on the mCC app.
Person of childbearing potential will be given a pregnancy test on study enrollment and asked to use contraception throughout the study.
Post-menopausal and individuals on hormone replacement therapy will be included.
Estimated Glomerular Filtration Rate (EGFR) \> 45
If participants are on cardiovascular medications (HMG CoA reductase inhibitors (statins), other lipid-modifying drugs, anti-hypertensives) no dose adjustments will be allowed during the study period
Participants on stable doses (consistent dose for ≥3 months) of GLP-1 receptor agonists will be included.

Exclusion Criteria

Participants with Type1DM and T2DM who are taking insulin, sulfonylureas, or have an HbA1c \> 9 %.
Estimated Glomerular Filtration Rate (EGFR) \< 45
Systolic BP greater than 160 mmHg and/or Diastolic BP greater than 110 mmHg (with or without treatment/medication)
LDL cholesterol greater than 200 mg/dL
Triglycerides greater than 500 mg/dL
Active tobacco or illicit drug use
Pregnant or breastfeeding individuals.
Currently enrolled in a weight-loss or weight-management program,
Currently on a special or prescribed diet for other reasons (e.g., Celiac disease),
On recently prescribed medication that is meant for weight loss, or has known effect on appetite suppression ( patient on stable dose for 3 months can be enrolled ).
History of eating disorder(s).
History of surgical intervention for weight management (e) active eating disorder.
Chronic kidney disease with an eGFR calculated based on the Modification of Diet in Renal Disease (MDRD) equation \<50mL/min/1.73m2
Treatment for active inflammatory and/or rheumatologic disease and cancer.
A major adverse cardiovascular event within the past 6 months such as acute coronary syndrome (ACS), percutaneous coronary intervention, coronary artery bypass graft surgery, hospitalization for congestive heart failure, stroke/transient ischemic attack (TIA).
History of Uncontrolled arrhythmia (i.e., rate-controlled atrial fibrillation/atrial flutter are not exclusion criteria) 18. Liver cirrhosis and/or significant alterations in liver function
History of (a) thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 3 months (i.e., hypothyroidism on a stable dose of thyroid replacement therapy is not an exclusion), Shift workers with variable (e.g., nocturnal) hours.
Caregivers for dependents requiring frequent nocturnal care/sleep interruptions.
More than one trip planned to travel to a time zone with greater than a 3-hour difference during study period.
History of major adverse cardiovascular events within the past 1 year (acute coronary syndrome (ACS), percutaneous coronary intervention, coronary artery bypass graft surgery, hospitalization for congestive heart failure, stroke/transient ischemic attack (TIA)).
History of thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 3 months (i.e., hypothyroidism on a stable dose of thyroid replacement therapy is not an exclusion).
History of adrenal disease.
History of malignancy undergoing active treatment, except non-melanoma skin cancer.
Known history of type I diabetes.
History of stage 4 or 5 chronic kidney disease or requiring dialysis.
History of HIV/AIDS.
Uncontrolled psychiatric disorder (including history of hospitalization for psychiatric illness).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in La Jolla?

Yes, this clinical trial (NCT06884059) has an active research site in La Jolla, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 2 Diabetes Mellitus (T2DM) Treatment Options in La Jolla, CA

If you're searching for type 2 diabetes mellitus (t2dm) treatment options in La Jolla, CA, this clinical trial (NCT06884059) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our La Jolla research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced type 2 diabetes mellitus (t2dm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 2 diabetes mellitus (t2dm) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in La Jolla, CA

See all pulmonary embolism clinical trials recruiting in La Jolla — not just this study.

Browse Pulmonary Embolism Trials in La Jolla →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in La Jolla?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · La Jolla, CA